NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Colorectal, Version 3.2017Samir Gupta, Ndiya Ogba, Dawn Provenzale et al.|Journal of the National Comprehensive Cancer Network|2017Cited by 215
NCCN Guidelines® Insights: Genetic/Familial High-Risk Assessment: Colorectal, Version 1.2021.Jennifer M. Weiss, Mallory Campbell, Seth Felder et al.|PubMed|2021Cited by 156
Effect of Sulindac and Erlotinib vs Placebo on Duodenal Neoplasia in Familial Adenomatous PolyposisN. Jewel Samadder, Scott K. Kuwada|JAMA|2016Cited by 142
Genetic/Familial High-Risk Assessment: Colorectal, Endometrial, and Gastric, Version 3.2024, NCCN Clinical Practice Guidelines In OncologyRachel Hodan, Zeenat Diwan, Samir Gupta et al.|Journal of the National Comprehensive Cancer Network|2024Cited by 91